| Metric | Current Period | Prior Year | YoY |
|---|---|---|---|
| Revenue / Net Sales | ¥56620.6B | ¥52829.8B | +7.2% |
| Operating Income | - | - | - |
| Ordinary Income | ¥11202.3B | ¥9289.9B | +20.6% |
| Net Income | ¥7918.6B | ¥6966.6B | +13.7% |
| ROE | 16.4% | 17.2% | - |
For the fiscal year ended March 2026, revenue / net sales were ¥5兆6,620B円 (YoY +¥3,790B +7.2%), ordinary income was ¥1兆1,202B円 (YoY +¥1,912B +20.6%), and profit attributable to owners of parent (net income) was ¥7,918B円 (YoY +¥952B +13.7%), resulting in higher revenue and profit. Premium income at overseas insurance subsidiaries grew double-digits to ¥1兆7,795B円 (+15.4%), and major domestic P&C insurers achieved significant profit increases driven by improved combined ratios. Investment income expanded with interest and dividends of ¥5,492B円 (+¥540B) and gains on sales of securities of ¥6,157B円 (+¥540B), and equity-method investment income rose to ¥368B円 (prior year ¥251B). The ordinary income margin improved roughly 190bp to about 19.8%, and ROE increased to 16.4% (YoY +2.9pt). Meanwhile, Mitsui Sumitomo Aioi Life recorded an ordinary loss of ¥127B円 (prior year ordinary income ¥506B) and the Group booked special losses of ¥994B円 (including impairment of ¥337B円), but final net profit still achieved double-digit growth.
[Revenue] Net written premiums plus life insurance premiums totaled ¥5兆6,620B円 (+7.2%). Overseas insurance subsidiaries drove growth with ¥1兆7,795B円 (+15.4%) led by increases in Europe and the Americas. Domestically, Mitsui Sumitomo Insurance recorded ¥1兆7,544B円 (+4.5%), Aioi Nissay Dowa ¥1兆4,711B円 (+2.9%), and Mitsui Sumitomo Primary Life ¥1兆2,932B円 (+9.9%), with core P&C and life businesses achieving revenue growth. Price revisions and an increase in contract counts contributed, maintaining a third consecutive period of topline growth.
[Profitability] Ordinary income rose to ¥1兆1,202B円 (+20.6%), a double-digit increase. The combined ordinary income of the two major domestic insurers improved significantly to ¥9,088B円 (+26.9%); the combined ratio improved to 95.0% (prior year 99.4%), a 4.4pt improvement, and net loss ratio declined to 63.6% (prior year 66.6%). Natural catastrophe claims decreased from ¥901B円 in the prior year to ¥253B円, and although provisions shifted to add to abnormal risk reserves, the improvement in loss ratio absorbed the impact. Overseas operations delivered substantial profit growth led by Europe and the U.S., with profit attributable to owners of parent of ¥2,618B円 (+42.0%). Investment income also lifted results via +¥540B in interest & dividends and +¥540B in gains on sales. Operating profit margin is estimated at around 16%, and ordinary income margin about 19.8%, indicating significant improvement in profitability. Special losses of ¥994B円 (including impairments ¥337B円 and other special losses ¥610B円) were recorded, partially offset by special gains of ¥314B円 (including ¥264B円 from sale of subsidiary shares), resulting in profit before tax of ¥1兆522B円 (+15.9%) and income taxes of ¥260B円 (effective tax rate about 25%), leading to profit attributable to owners of parent of ¥7,918B円 (+13.7%).
On a reported-segment basis (profit attributable to owners of parent), Mitsui Sumitomo Insurance (core business) delivered ¥4,599B円 (prior year ¥4,599B円 +0.0%), Aioi Nissay Dowa ¥1,580B円 (prior year ¥1,087B円 +45.4%), overseas insurance subsidiaries ¥2,618B円 (prior year ¥1,844B円 +42.0%), Mitsui Sumitomo Primary Life ¥323B円 (prior year ¥257B円 +25.7%), while Mitsui Direct General Insurance continued in the red at ▲¥19B円 (prior year ▲¥17B円), and Mitsui Sumitomo Aioi Life turned to a loss of ▲¥519B円 (prior year ¥296B円). Mitsui Sumitomo Insurance and overseas insurance subsidiaries accounted for approximately 62% of total profit, highlighting notable profitability improvement in domestic P&C. Mitsui Sumitomo Insurance revenue was ¥1兆7,544B円 (+4.5%), Aioi Nissay Dowa ¥1兆4,711B円 (+2.9%), and overseas insurance subsidiaries ¥1兆7,795B円 (+15.4%), with overseas driving high growth. By segment profit growth rate, Aioi Nissay Dowa increased strongly at +45.4%, overseas profit expanded +42.0%, while the loss at Mitsui Sumitomo Aioi Life (▲¥519B円) weighed on consolidated profitability. By region, Europe recorded ¥1兆2,461B円 (+12.9%) revenue and profit ¥1,380B円 (+62.9%), Americas ¥1,833B円 (+28.7%) revenue and profit ¥396B円 (+76.3%), and Asia ¥3,056B円 (+8.8%) revenue and profit ¥526B円 (▲0.4%), showing revenue increases in Asia but slight profit decline.
Profitability: ROE 16.4% (prior year 13.5%), estimated operating profit margin approx. 16%, ordinary income margin about 19.8%, and net profit margin 14.0%, representing roughly 190bp improvement from prior year. Cash quality: Operating Cash Flow (OCF) ¥7,626B円, 1.79x of net income, Free Cash Flow ¥656B円 (OCF minus capital expenditures ¥322B円). OCF/EBITDA at 0.62x is low, reflecting significant impact from insurance liabilities and working capital movements. Investment efficiency: capital expenditures ¥322B円 / depreciation ¥1,003B円 = 0.32x, indicating restrained renewal investment; unamortized goodwill balance ¥1,267B円 (2.6% of net assets) is modest. Financial soundness: Equity Ratio 16.8% (prior year 15.4%), debt-to-equity ratio 4.94x indicating high leverage driven by liabilities predominantly comprised of insurance contract reserves. After share buybacks of ¥2,215B円, treasury stock balance shrank to ¥1,506B円 (prior year ¥2,855B円), improving capital efficiency. Retained earnings ¥2兆4,853B円 (prior year ¥2兆1,353B円, +16.4%) have accumulated, strengthening capital capacity.
OCF: ¥7,626B円 (prior year ¥6,602B円 +15.5%), 1.79x of net income ¥7,918B円, indicating high quality. However, OCF/EBITDA at 0.62x is low, and increases in insurance contract reserves and unpaid insurance claims (+¥10,574B円) as well as working capital movements related to derivative settlements and collateral reduced cash conversion. Investing CF: ▲¥6,970B円 (prior year ▲¥5,587B円), with large purchases of securities at ▲¥96,650B円 offset by substantially higher proceeds from sales, and continued active investment in loan receivables and other assets. CapEx was ¥322B円 (prior year ¥252B円), focusing on renewal investment, with CapEx/Depreciation at 0.32x. Financing CF: ▲¥1,292B円 (prior year ▲¥6,595B円), with bond issuance of ¥4,560B円 (redemptions ▲¥500B円) while distributing dividends ▲¥2,248B円 and repurchasing shares ▲¥2,215B円 as total shareholder returns. Free Cash Flow was ¥656B円 (OCF ¥7,626B円 - CapEx ¥322B円), which was insufficient to cover dividend + buybacks of ▲¥4,463B円, resulting in total returns significantly exceeding internally generated cash. Cash generation assessment: while OCF is high, large working capital fluctuations mean sustainability of total returns depends on realization of investment income and external financing such as bond issuance.
Against ordinary income of ¥1兆1,202B円, profit attributable to owners of parent was ¥7,918B円, with tax burden and non-controlling interests deducted from ordinary → net profit. Special losses of ¥994B円 (impairment ¥337B円, transfer to price fluctuation reserve ¥116B円, other special losses ¥610B円) temporarily pressured net income but were partly offset by special gains of ¥314B円 (including ¥264B円 from sale of subsidiary shares). Non-operating income included interest & dividends ¥5,492B円, monetary trust account gains ¥2,751B円, and gains on sale of securities ¥6,157B円, making investment income a large component and sensitive to market conditions. Securities valuation losses of ¥51B円 were minor, and stable realization of investment income was observed. OCF being 1.79x of net income and an accrual ratio of -1.2% indicate strong cash backing of earnings. However, the tax burden factor in the five-factor DuPont is 0.40, appearing low, which should be interpreted considering the impact of equity-method income/losses and valuation gains/losses increasing the apparent tax burden in the metric.
For the fiscal year ending March 2027 (FY2026 forecast), insurance revenue (post-IFRS adoption) is projected at ¥7兆円 (+9.8%), and profit attributable to owners of parent is projected at ¥425B円 (▲46.0%), a substantial decline. The profit reduction reflects the impact of transition to IFRS and conservative estimates for domestic natural catastrophe claims (Mitsui Sumitomo Insurance ¥830B円 + Aioi Nissay Dowa ¥670B円 = total ¥1,500B円). In FY2025 actuals, natural catastrophe claims were only ¥253B円, but assumptions have been significantly tightened for FY2026. Overseas forecasts assume market interest rates and markets do not materially change from end-March levels. Annual dividend is forecast at ¥170 (up ¥10), implying a payout ratio of about 40% (on IFRS profit forecast), with continued emphasis on stabilizing DOE. Progress evaluation is consistent between full-year forecast and results, and quarterly disclosures are not required; full-year priorities emphasize portfolio optimization and profitability improvement both overseas and domestically.
The FY2025 annual dividend was ¥160 (interim ¥77.5, year-end ¥82.5), and on profit attributable to owners of parent of ¥7,918B円 the payout ratio was 32.5%, a reasonable level. Total return ratio was (dividends ¥2,248B円 + share buybacks ¥2,215B円) / net income ¥7,918B円 = 56.3%, maintaining a high-return policy. However, Free Cash Flow ¥656B円 versus total returns ¥4,463B円 represents a 6.8x excess of distributions over FCF, with cash coverage of 0.15x. Return funding was provided by realization of investment income (gains on sale of securities ¥6,157B円 etc.), bond issuance (increase in corporate bonds outstanding ¥4,078B円), and beginning cash balances. DOE is around 5.3%, and continuation is judged feasible given capital buffer (equity ¥4兆8,251B円), but going forward sustainability of distributions depends on realization of investment income, recovery of life insurance business profitability, and overseas profit growth. For FY2026 the dividend forecast is ¥170 (up ¥10), indicating continued reinforcement of shareholder returns via staged increases in ordinary dividends and flexible use of special dividends.
[Short-term] Natural catastrophe occurrences domestically and overseas in Q1 2026, concrete progress of profit recovery measures at Mitsui Sumitomo Aioi Life, disclosure of insurance revenue and insurance service expense under IFRS in the first year of application, quarterly trends in investment income (interest & dividends, gains on sale of securities) and sensitivity to market conditions, and confirmation of sustained effects of price revisions and combined ratio improvements at the two major domestic insurers.
[Long-term] Sustainability of scale expansion and margin improvement at overseas insurance subsidiaries, progress in portfolio optimization across Europe, Americas, and Asia, expense ratio improvements from digitalization and DX in domestic P&C, completion of product/ALM/sales channel restructuring and return to profitability at Mitsui Sumitomo Aioi Life, optimal capital allocation to achieve Group ROE targets, and advancement of underwriting sophistication and premium rationalization through strengthened ESG and climate-change responses.
Profitability & Returns
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Net Profit Margin | 14.0% | 4.3% (0.6%–11.3%) | +9.7pt |
| The company’s net profit margin substantially exceeds the industry median, reflecting a high-return structure driven by investment income and loss-ratio control. |
Growth & Capital Efficiency
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Revenue Growth Rate (YoY) | 7.2% | 2.1% (-4.5%–6.9%) | +5.1pt |
| Revenue growth outperformed the industry median by 5.1pt, driven by overseas expansion and revenue increases at core domestic P&C insurers. |
※ Source: Company aggregation of public financial statements
Natural Catastrophe Risk: While natural catastrophe claims for the two major domestic insurers totaled only ¥253B円 in FY2025, the FY2026 assumption is ¥1,500B円, representing a markedly conservative premise. In the event of frequent large-scale typhoons, floods, earthquakes, etc., the loss ratio could spike and profits could be significantly compressed. Overseas had previously recognized the January 2025 California wildfires in advance, but recurrence of similar large disasters would pose the risk of additional special loss recognition.
Investment Income Volatility Risk: In FY2025 investment income (interest & dividends ¥5,492B円, gains on sale of securities ¥6,157B円, monetary trust account gains ¥2,751B円) accounted for roughly 80% of ordinary income. A reversal in market interest rates or a decline in equity markets could crystallize valuation losses or sale losses, causing investment income to fall sharply. The securities balance of ¥19兆7,695B円 has high sensitivity to interest rates and equity prices, and rapid external changes would increase earnings volatility.
Life Insurance Business Loss Expansion Risk: Mitsui Sumitomo Aioi Life turned to an ordinary loss of ¥127B円 and a profit attributable to owners of parent of ▲¥519B円. Increased provisions for reserves, deterioration in valuation of insurance liabilities due to interest rate movements, and expanded securities valuation losses are key drivers. Delays in corrective measures or unfavorable interest rate conditions could prolong or expand losses, weighing on consolidated profit.
Overseas operations and investment income led double-digit profit growth, confirming superior profitability within the domestic P&C industry with ROE improving to 16.4% and ordinary income reaching ¥1兆1,202B円 (+20.6%). Revenue and profit growth in Europe and the Americas was notable, and profit attributable to owners of parent from overseas insurance subsidiaries of ¥2,618B円 (+42.0%) is a future growth driver. As long as market interest rates remain elevated and equity markets stay firm, investment income should remain resilient, and improved combined ratios at the two major domestic insurers (95.0% vs prior year 99.4%) are expected to continue. However, high reliance on investment income warrants caution regarding volatility at times of market reversals.
The turn to loss at Mitsui Sumitomo Aioi Life (ordinary loss ¥127B円, profit attributable to owners of parent ▲¥519B円) is a drag on consolidated profit, making the concretization and progress of remedial measures a focal point for FY2026. Enhanced disclosure under IFRS should clarify interest-rate sensitivity of insurance liabilities and ALM positions, improving transparency of risk-return for investors.
Total returns of ¥4,463B円 versus Free Cash Flow ¥656B円 results in insufficient coverage, but substantial capital buffer (equity ¥4兆8,251B円) and bond issuance have provided return funding. The FY2026 dividend forecast of ¥170 (up ¥10) reflects a policy to stabilize DOE and gradually raise ordinary dividends, signaling intention to strengthen shareholder returns over the medium to long term. However, sustainability of distributions beyond next fiscal year depends on realization of investment income, return to profitability in life insurance, and overseas profit expansion.
This report was auto-generated by AI through integrated analysis of XBRL financial statement data and PDF earnings presentation materials. It does not constitute a recommendation to invest in any particular security. Industry benchmarks are reference information compiled by the company based on publicly available financial statements. Investment decisions should be made at your own responsibility and, where appropriate, after consulting a professional advisor.